# Longevity & Cellular Health Peptide FAQ — Epitalon and NAD+ — Highlander Peptide

> Frequently asked questions about Epitalon and NAD+, two Longevity & Cellular Health research compounds — answered from the peer-reviewed literature, with citations.

Precise, citation-anchored answers to the questions readers most often bring to these two longevity research compounds.

## What is epitalon?

Epitalon is a synthetic tetrapeptide — four amino acids in the sequence Ala-Glu-Asp-Gly (AEDG) — derived from the composition of epithalamin, a polypeptide extract of the bovine pineal gland. It is also called Epithalon or the AEDG peptide. In research it has been studied for two proposed mechanisms: upregulating the catalytic telomerase subunit (hTERT) to extend telomere length in cultured human cells [4][2], and stimulating melatonin-synthesis enzymes in rat pinealocyte culture [3]. It is not an approved drug or supplement anywhere in major Western markets and is classified as a research chemical [1].

## What are the benefits of epitalon according to research?

The peer-reviewed evidence associates Epitalon with: telomere elongation in normal human cell lines via hTERT upregulation (2003 and 2025 cell studies [4][2]); stimulation of melatonin synthesis in rat pinealocytes [3]; a 12.3% increase in maximum lifespan and sixfold reduction in leukemia incidence in female SHR mice at one dose, without increased total tumor incidence [6]; and reduced reactive oxygen species in mouse oocytes [7]. The human-level evidence is an observational cohort study of 266 elderly persons using epithalamin (the bovine extract, not synthetic Epitalon), which lacks randomization and a placebo arm and therefore cannot cleanly attribute benefit to the compound [5]. None of this constitutes approved clinical evidence of benefit in humans.

## What is the recommended dosage of epitalon in research protocols?

This desk does not provide human dosing information for Epitalon. The animal and cell studies used doses such as 1.0 ug/mouse subcutaneously over five days per month in the lifespan study [6] and 0.1-1 ug/mL in human cell culture [2] — these are experimental doses in specific model systems, not human dosing protocols. There are no published human pharmacokinetic data for Epitalon and no controlled clinical trial in humans that established a safe or effective dose. Any dosing information circulating in community settings is extrapolated from preclinical work and has no controlled-trial validation.

## How often should epitalon be cycled, once or twice a year?

There is no peer-reviewed evidence that establishes a cycling protocol for Epitalon in humans. Cycling recommendations circulating in longevity forums are based on inference from the mouse study design (five days per month) or on anecdotal community convention, not on human pharmacokinetic or clinical data. There is no published human PK study of the compound — even its half-life in humans is an extrapolation, not a measured value [1]. This site does not advise on Epitalon cycling or use.

## What is NAD supplement used for?

In research, NAD+ precursors (NMN and NR) are studied primarily for two categories of effect: raising blood and cellular NAD+ levels (now well-established in multiple RCTs [9][12]) and downstream functional endpoints related to aging biology — metabolic health, muscle function, physical performance, and potentially DNA repair and sirtuin activity [11][10]. The rationale is that NAD+ declines with age and restoring it may partly restore the function of NAD-dependent enzymes such as sirtuins and PARPs. In the wellness market, oral precursors are sold as energy and longevity supplements; IV infusion of compounded NAD+ is offered in some clinical and wellness settings. This site does not advise on use.

## What is the downside of taking NAD+?

Oral NAD+ capsules are largely considered ineffective at raising intracellular NAD+ because NAD+ is poorly absorbed intact — precursors (NMN or NR) are the rational oral approach [8]. For oral NMN and NR, the human RCT data show a favorable safety profile at studied doses [9][12]. However: translating elevated blood NAD+ to hard clinical benefits in healthy adults has not been convincingly demonstrated — the 2025 Nature Metabolism review characterizes human clinical translation as limited [8]. IV NAD+ wellness therapy carries additional risks: infused NAD+ clears rapidly from plasma; infusions run too quickly can cause chest discomfort, abdominal cramps, flushing, and nausea; and a compounded IV NAD+ product was subject to a Class I FDA recall for bacterial endotoxin contamination [8]. A theoretical concern also exists that elevated NAD+ could support the metabolism of existing cancers [11].

## Is it safe to take NAD daily?

Daily oral supplementation with NMN or NR was well tolerated in the human RCTs this desk cites: 300-900 mg/day NMN for 60 days showed no safety signals in a multicenter double-blind trial [9], and NR at 100-1000 mg/day for 8 weeks showed no significant adverse-event differences from placebo at any dose, with no flushing and no LDL elevation [12]. These trials do not constitute long-term safety data; they cover two to four months in specific populations. Long-term daily supplementation safety in diverse populations has not been established. This site does not advise on whether any individual should take any supplement.

## Does NAD cause weight gain?

The published human RCTs do not report weight gain as a result of NMN or NR supplementation. The 10-week NMN study in prediabetic postmenopausal women found no change in body composition despite improved muscle insulin sensitivity [10], and the NR dose-response trial found no change in body weight compared to placebo [12]. The theoretical argument runs in the opposite direction — NAD+ supports mitochondrial activity and sirtuin pathways that are implicated in metabolic health — but this desk reports what controlled studies found, not theoretical projections. No clinical trial has shown NAD+ precursor supplementation causes weight gain.

## Is epitalon the same as epithalamin?

No, and the distinction matters for interpreting the evidence. Epithalamin is a polypeptide extract from bovine pineal glands — a mixture of peptides. Epitalon (AEDG) is a defined synthetic tetrapeptide derived from the amino-acid composition of epithalamin but chemically distinct from it. The most-cited human evidence — the 6-8 year observational cohort study reporting reduced mortality [5] — used epithalamin, not synthetic Epitalon. Extrapolating that result directly to Epitalon as a compound is an evidence jump, because the two molecules are not the same [1]. Most of the cell and animal work cited in the literature uses synthetic Epitalon specifically.

## Does telomere lengthening from Epitalon mean it is anti-aging?

The connection between telomere length and biological aging is real and well supported in basic science — shorter telomeres correlate with cellular senescence and age-related disease risk. But the causal arrow is less clean than popular accounts suggest: lengthening telomeres in a cell-culture system does not straightforwardly translate to extended healthy lifespan in a living person. The 2025 Biogerontology study [2] confirmed Epitalon extends telomere length in normal human cell lines via hTERT upregulation — that is a genuine and independently replicated finding. The same study also found that Epitalon extended telomere length in breast-cancer cell lines, through a different mechanism (ALT). The oncological implications of activating these pathways systemically in humans are unresolved [1]. "Telomere lengthening in a dish" and "demonstrated longevity benefit in humans" are not equivalent claims.

---

A peer-reviewed literature digest for longevity and cellular health research — citations held to source, claims held to species.